DXB
Click for more information
3.92% 53.0¢ dimerix limited

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal...

  1. shlok
    100 Posts.
    lightbulb Created with Sketch. 21
    clock Created with Sketch.
    02/04/24
    14:44
    Post #: 73149921
    PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

    As far as I can find:

    https://clinicaltrials.gov/study/NCT03763643

    this is the only randomised trial underway due for completion in 2026 and this is for post transplant patients.

    DXB Price at posting: 29.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
53.0¢ 		Change
0.020(3.92%) 		Mkt cap ! $291.6M
Open High Low Value Volume
51.0¢ 53.8¢ 51.0¢ $782.0K 1.490M

Buyers (Bids)

No. Vol. Price($)
1 6408 53.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.5¢ 35657 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.